Biological meshes for abdominal hernia: Lack of evidence-based recommendations for clinical use

被引:16
|
作者
Trippoli, Sabrina [1 ]
Caccese, Erminia [1 ]
Tulli, Giorgio [2 ]
Ipponi, Pierluigi [3 ]
Marinai, Claudio [1 ]
Messori, Andrea [1 ]
机构
[1] ESTAR, HTA Unit, Reg Hlth Serv, I-50135 Florence, Italy
[2] Reg Hlth Agcy, Florence, Italy
[3] Surg Unit, Florence, Italy
关键词
Abdominal surgery; Biological meshes; Synthetic meshes; Post-surgical infection; Post-surgical recurrence; Meta-analysis; WALL RECONSTRUCTION; TERM OUTCOMES; REPAIR; PERMACOL(TM); MATRIX; REINFORCEMENT; METAANALYSIS; DEFECTS; IMPLANT; IMPACT;
D O I
10.1016/j.ijsu.2018.02.046
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: In the clinical literature on abdominal hernia repair, no sound criteria have been established to support the use of biological meshes as opposed to synthetic ones. Furthermore, the information on biological meshes is quite scarce, and so their place in therapy has not yet been defined. Methods: The treatment of primary and incisional ventral hernia was the target intervention evaluated in our analysis. Our study consisted of the following phases: a) Identification of the biologic meshes available on the market; b) Literature search focused on efficacy and safety of these meshes; c) Analysis of the findings derived from the literature search. The information collected this way was reviewed narratively, and presented according to standard meta-analysis. The main end-points of our analysis included infection of surgical wound at 1 month and recurrence at 12 months. Results: Our clinical literature comprised 11 trials that evaluated 5 biological meshes: Permacol (706 patients), Strattice (324 patients), Surgisis (44 patients), Tutomesh (38 patients) and Xenmatrix (22 patients). These studies generally showed a poor methodological quality. Surgical wound infection showed a wide between-study variability (95% CI: from 12.0% to 22.9%). Also the 12-month relapse rate demonstrated a wide 95% CI (from 5.0% to 19.9%). A significantly lower rate of recurrence at 12 months was found for Permacol compared with Strattice (rate difference: -14.2%; 95% CI: -22.1% to -6.2%). Discussion: Our analysis provided an overview of 5 biological meshes currently available on the market. The different types of meshes showed a marked statistical variability in the clinical outcomes. Hence, nearly all comparisons between different meshes in the two clinical end-points did not reach statistical significance. One exception was represented by the finding that cross-linked meshes had a significantly lower recurrence rate at 12 months than non-cross-linked meshes.
引用
收藏
页码:286 / 292
页数:7
相关论文
共 50 条
  • [1] Evidence-based recommendations for the clinical use of rhEPO
    Muirhead, N
    PATHOGENETIC AND THERAPEUTIC ASPECTS OF CHRONIC RENAL FAILURE, 1997, : 137 - 161
  • [2] Biological meshes: A review of their use in abdominal wall hernia repairs
    Smart, Neil J.
    Marshall, Morwena
    Daniels, Ian R.
    SURGEON-JOURNAL OF THE ROYAL COLLEGES OF SURGEONS OF EDINBURGH AND IRELAND, 2012, 10 (03): : 159 - 171
  • [3] The Use of Biological Meshes in Diaphragmatic Defects - An Evidence-Based Review of the Literature
    Antoniou, Stavros A.
    Pointner, Rudolph
    Granderath, Frank-Alexander
    Koeckerling, Ferdinand
    FRONTIERS IN SURGERY, 2015, 2
  • [4] Evidence-based clinical recommendations for fluoride use: a review
    Mani, Shani Ann
    ARCHIVES OF OROFACIAL SCIENCE, 2009, 4 (01): : 1 - 6
  • [5] Use of cholinesterase inhibitors in clinical practice - Evidence-based recommendations
    Cummings, JL
    AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY, 2003, 11 (02): : 131 - 145
  • [6] Recommendations for the use of antiemetics: Evidence-based, clinical practice guidelines
    Gralla, RJ
    Osoba, D
    Kris, MG
    Kirkbride, P
    Hesketh, PJ
    Chinnery, LW
    Clark-Snow, R
    Gill, DP
    Groshen, S
    Grunberg, S
    Koeller, JM
    Morrow, GR
    Perez, EA
    Silber, JH
    Pfister, DG
    JOURNAL OF CLINICAL ONCOLOGY, 1999, 17 (09) : 2971 - 2994
  • [7] Synthetic Versus Biological Mesh in Ventral Hernia Repair and Abdominal Wall Reconstruction: A Systematic Review and Recommendations from Evidence-Based Medicine
    Hekai Shi
    Rui Wang
    Wenpei Dong
    Dongchao Yang
    Heng Song
    Yan Gu
    World Journal of Surgery, 2023, 47 : 2416 - 2424
  • [8] Synthetic Versus Biological Mesh in Ventral Hernia Repair and Abdominal Wall Reconstruction: A Systematic Review and Recommendations from Evidence-Based Medicine
    Shi, Hekai
    Wang, Rui
    Dong, Wenpei
    Yang, Dongchao
    Song, Heng
    Gu, Yan
    WORLD JOURNAL OF SURGERY, 2023, 47 (10) : 2416 - 2424
  • [9] EVIDENCE-BASED RECOMMENDATIONS FOR THE CLINICAL USE OF RECOMBINANT-HUMAN-ERYTHROPOIETIN
    MUIRHEAD, N
    BARGMAN, J
    BURGESS, E
    JINDAL, KK
    LEVIN, A
    NOLIN, L
    PARFREY, P
    AMERICAN JOURNAL OF KIDNEY DISEASES, 1995, 26 (02) : S1 - S24
  • [10] Evidence-based recommendations for the use of antiemetics in radiotherapy
    Maranzano, E
    Feyer, PC
    Molassiotis, A
    Rossi, R
    Clark-Snow, RA
    Olver, I
    Warr, D
    Schiavone, C
    Roila, F
    RADIOTHERAPY AND ONCOLOGY, 2005, 76 (03) : 227 - 233